Form 4: Encompass Health Director Acquires Additional Shares Through Dividend Reinvestment

Sentiment:

SEC Form 4


Greg D. Carmichael, a director at Encompass Health Corp, acquired additional shares through a dividend reinvestment program.

Summary

  • On April 15, 2025, Greg D. Carmichael, a director of Encompass Health Corp, acquired 23 shares of Encompass Health common stock.
  • This acquisition was a result of dividend payments on outstanding restricted stock units (RSUs).
  • Encompass Health paid a dividend of $0.17 per share, and the closing price of the stock on that day was $102.30.
  • Following the transaction, Carmichael directly owns 17,160 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's participation in the dividend reinvestment program is a positive sign, but the transaction itself is routine.

Positives

  • The director's participation in the dividend reinvestment program demonstrates confidence in the company's future.

Industry Context

Dividend reinvestment programs are common practices for companies to reward shareholders and encourage long-term investment. Directors participating in such programs can signal positive sentiment about the company's prospects.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it signals confidence from a company director.

Key Dates

DateDescription
04/15/2025Date of transaction: Acquisition of shares through dividend reinvestment.
04/16/2025Date of signature on the Form 4 filing.

Keywords

Encompass Health, Director, Carmichael, Dividend Reinvestment, Shares, Acquisition, RSU, EHC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.